The same approach was used to validate that an anti-inflammatory LAMP1+TRAIL+ astrocyte subpopulation that was reduced in EAE compared to naïve mice, was also downregulated in MS (Sanmarco et al., 2021). Here, TNFSF10 is linked to myeloid sarcoma.